Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
Unchalee Permsuwan,1,2 Krit Leemasawat,3 Poukwan Arunmanakul1,2,4 1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Center for Medical and Health Technology Assessment (CM-HTA), Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai Un...
Saved in:
| Main Authors: | Permsuwan U, Leemasawat K, Arunmanakul P |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/adding-tolvaptan-in-the-inpatient-treatment-for-patients-with-heart-fa-peer-reviewed-fulltext-article-CEOR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe tolvaptan-associated hyperglycemia: a case report
by: Huihuan Sun, et al.
Published: (2025-07-01) -
Recurrent hyponatremia due to syndrome of inappropriate antidiuresis after traumatic brain injury: two case reports
by: Iulia Petria, et al.
Published: (2025-03-01) -
Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5
by: Akinari Sekine, et al.
Published: (2025-06-01) -
Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report
by: Hiroya Iida, et al.
Published: (2020-03-01) -
PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE
by: D. Yu. Shchekochikhin, et al.
Published: (2015-09-01)